NDC codes

FDA NDC Directory
Product NDC (as listed)73070-103Labeler and product segments. Claims need a package NDC.
Product NDC at billing width73070-0103Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
73070-103-1573070010315730700103155 SYRINGE, PLASTIC in 1 CARTON (73070-103-15) / 3 mL in 1 SYRINGE, PLASTIC (73070-103-10)Marketed from Sep 10, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Insulin Aspart
Generic name (nonproprietary)
insulin aspart
Active ingredients
Insulin aspart — 100 [iU]/mL
Dosage form
Injection, Solution
Route
Intravenous, Subcutaneous
Labeler
Novo Nordisk Pharma, Inc.NDC labeler code 73070
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 020986
Marketing start
Marketing end
Other FDA classes
Insulin (Chemical structure)
Identifiers
Product ID 73070-103_18e1bdfe-0180-4988-9797-5ee4660e3840SPL ID 18e1bdfe-0180-4988-9797-5ee4660e3840SPL set ID bee5b358-c863-420b-be73-ced2e920c499RxCUI 311040, 1653196, 1653202UNII D933668QVX
Pharmacologic class
Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N473070010315 followed by a unit qualifier and the quantity

Package 73070-0103-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Insulin Aspart is indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus. Insulin Aspart is rapid acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with diabetes mellitus ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73070-103

What is NDC 73070-103?
73070-103 is the product NDC for Insulin Aspart, Insulin aspart 100 [iU]/mL injection, solution, listed with the FDA by Novo Nordisk Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Insulin Aspart.
What is the active ingredient?
Insulin aspart.
Who is the labeler?
Novo Nordisk Pharma, Inc., NDC labeler code 73070. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Insulin Aspart?
5 other product NDCs are listed under this name. See all Insulin Aspart NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Insulin Aspart NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousREMEDYREPACK INC.70518-386570518-3865-00
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-495650090-4956-00
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-495550090-4955-00
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk Pharma, Inc.73070-10073070-0100-11
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk Pharma, Inc.73070-10273070-0102-15

Other NDCs under BLA 020986

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 020986
ProductStrengthForm · routeLabelerProduct NDC
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-4955
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-4956
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousREMEDYREPACK INC.70518-3865
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk Pharma, Inc.73070-100
Insulin AspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk Pharma, Inc.73070-102
Insulin Diluting Medium for NovoLogwater injectionWater 1 mL/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-2001
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-2100
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-2101
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-3303
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-6338
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-6339
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousNovo Nordisk0169-7501
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-1664
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-1678
Novologinsulin aspartInsulin aspart 100 [iU]/mLInjection, SolutionIntravenous, SubcutaneousA-S Medication Solutions50090-4500

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in